Smith & Nephew plc (LON:SN.)

Market Cap	9.43B
Revenue (ttm)	4.64B
Net Income (ttm)	329.09M
Shares Out	875.05M
EPS (ttm)	0.38
PE Ratio	28.70
Forward PE	14.50
Dividend	0.28 (2.58%)
Ex-Dividend Date	Mar 27, 2025

Volume	1,380,610
Average Volume	2,203,863
Open	1,102.00
Previous Close	1,109.50
Day's Range	1,094.00 - 1,107.50
52-Week Range	911.00 - 1,245.26
Beta	0.63
RSI	47.81
Earnings Date	Jul 31, 2025

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1856
• Employees: 17,349
• Stock Exchange: London Stock Exchange
• Ticker Symbol: SN.

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD